Minnesota · 2025-2026 Regular Session · Bill

SF 4189: Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases

In committee Last action April 7, 2026: Author added Miller

Plain-language summary

SF 4189 is a bill introduced in the Minnesota Senate on March 5, 2026. According to its official title, it concerns: Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases. Primary sponsor: Julia Coleman (Republican). It lists 4 additional sponsors. Most recent recorded action (April 7, 2026): Author added Miller.

Sponsors

Primary sponsor: Julia Coleman (Republican). 4 co-sponsors.